Oral fluconazole 200 mg daily for 2 weeks is the antifungal of choice for this diabetic patient with Candida cystitis.
For a diabetic patient with symptomatic Candida UTI (evidenced by 20-30 pus cells), oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks is the recommended first-line treatment, assuming fluconazole-susceptible Candida species 1.
Treatment Algorithm
Step 1: Determine if Treatment is Indicated
- Treat this patient: The presence of 20-30 pus cells indicates pyuria and symptomatic infection, not just colonization
- Diabetic patients are at higher risk for ascending infection and disseminated candidiasis 2, 3
- Treatment is warranted even without other high-risk features (neutropenia, urologic procedures planned) 1
Step 2: First-Line Therapy
Fluconazole 200 mg orally once daily for 2 weeks 1
Why fluconazole?
- Achieves high urinary concentrations with oral formulation 4, 2
- Available in both oral and IV forms
- Excellent safety profile
- Strong recommendation with moderate-quality evidence for fluconazole-susceptible organisms 1
Step 3: Essential Adjunctive Measures
Beyond antifungal therapy, address these critical factors:
- Remove or replace urinary catheter if present (strong recommendation) 1
- Optimize glycemic control - hyperglycemia promotes fungal growth and impairs immune response 3, 5
- Eliminate urinary obstruction if identified 1
- Discontinue unnecessary antibiotics that may have predisposed to candiduria 2, 6
Step 4: Alternative Regimens (if fluconazole cannot be used)
For fluconazole-resistant C. glabrata:
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days, OR
- Oral flucytosine 25 mg/kg four times daily for 7-10 days 1
For C. krusei (intrinsically fluconazole-resistant):
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
Critical Pitfalls to Avoid
Do NOT use echinocandins or non-fluconazole azoles (voriconazole, posaconazole, itraconazole) as first-line therapy for Candida UTI - they achieve inadequate urinary concentrations and have documented treatment failures 4, 7, 6.
Do NOT assume all candiduria requires treatment - but this patient's pyuria (20-30 pus cells) indicates true infection, not colonization 1, 4.
Do NOT rely on bladder irrigation alone - amphotericin B bladder irrigation (50 mg/L sterile water daily for 5 days) may be useful only as adjunctive therapy for fluconazole-resistant cystitis, not as monotherapy 1.
Special Considerations for Diabetic Patients
Diabetic patients face bidirectional complications:
- UTIs worsen glycemic control through stress responses and insulin resistance 3
- Poor glycemic control enhances bacterial/fungal adhesion, biofilm formation, and immune evasion 3, 5
- Risk of fungal bezoar ("fungus ball") formation, particularly with C. tropicalis or C. albicans, which can cause urinary obstruction 8, 9
Monitor closely for:
- Persistent symptoms despite treatment (may indicate biofilm formation or resistant species) 8, 5
- Ascending infection to kidneys (pyelonephritis requires higher fluconazole doses: 200-400 mg daily) 1
- Visible fungal masses in urine (rare but requires histopathological examination and possible surgical intervention) 8, 9
When to Obtain Species Identification and Susceptibility Testing
Obtain fungal culture with species identification and susceptibility testing if:
- No clinical improvement after 48-72 hours of fluconazole
- Previous fluconazole exposure or known resistant species in your institution
- Recurrent candiduria
- Critically ill or immunocompromised patient
This allows targeted therapy adjustment based on resistance patterns, particularly important for C. glabrata (variable fluconazole susceptibility) and C. krusei (intrinsically resistant) 1, 2.